PRINCIPAL FINANCIAL GROUP INC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 120 filers reported holding ANIKA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,249,477
-13.7%
86,585
-4.6%
0.00%0.0%
Q1 2023$2,606,570
-4.1%
90,758
-1.2%
0.00%0.0%
Q4 2022$2,719,233
+22.9%
91,866
-1.1%
0.00%0.0%
Q3 2022$2,212,000
+1.5%
92,930
-4.8%
0.00%0.0%
Q2 2022$2,179,000
-16.3%
97,620
-5.9%
0.00%0.0%
Q1 2022$2,604,000
-33.2%
103,699
-4.6%
0.00%0.0%
Q4 2021$3,896,000
-20.0%
108,732
-4.9%
0.00%
-33.3%
Q3 2021$4,868,000
-2.8%
114,378
-1.1%
0.00%0.0%
Q2 2021$5,008,000
+10.1%
115,695
+3.8%
0.00%0.0%
Q1 2021$4,547,000
-8.5%
111,470
+1.5%
0.00%
-25.0%
Q4 2020$4,969,000
+8.7%
109,788
-15.0%
0.00%0.0%
Q3 2020$4,573,000
+0.4%
129,229
+7.1%
0.00%0.0%
Q2 2020$4,554,000
+37.0%
120,690
+5.0%
0.00%0.0%
Q1 2020$3,324,000
-46.3%
114,992
-3.7%
0.00%
-20.0%
Q4 2019$6,193,000
+3.8%
119,444
+9.9%
0.01%0.0%
Q3 2019$5,967,000
+28.9%
108,712
-4.6%
0.01%
+25.0%
Q2 2019$4,628,000
+34.0%
113,943
-0.2%
0.00%
+33.3%
Q1 2019$3,453,000
-11.0%
114,197
-1.0%
0.00%
-25.0%
Q4 2018$3,878,000
-24.7%
115,375
-5.5%
0.00%
-20.0%
Q3 2018$5,149,000
+35.1%
122,081
+2.5%
0.01%
+25.0%
Q2 2018$3,812,000
-34.8%
119,132
+1.3%
0.00%
-33.3%
Q1 2018$5,846,000
-5.1%
117,585
+3.0%
0.01%0.0%
Q4 2017$6,157,000
-4.0%
114,209
+3.3%
0.01%0.0%
Q3 2017$6,411,000
+16.6%
110,541
-0.8%
0.01%0.0%
Q2 2017$5,500,000
+7.8%
111,467
-5.1%
0.01%0.0%
Q1 2017$5,103,000
-8.1%
117,461
+3.6%
0.01%
-14.3%
Q4 2016$5,554,000
+6.7%
113,433
+4.3%
0.01%0.0%
Q3 2016$5,204,000
-7.7%
108,755
+3.4%
0.01%
-12.5%
Q2 2016$5,641,000
+28.4%
105,151
+7.0%
0.01%
+33.3%
Q1 2016$4,394,000
+19.4%
98,251
+1.9%
0.01%
+20.0%
Q4 2015$3,681,000
+25.5%
96,457
+4.6%
0.01%0.0%
Q3 2015$2,934,000
-0.3%
92,179
+3.5%
0.01%
+25.0%
Q2 2015$2,943,000
-22.3%
89,101
-3.2%
0.00%
-33.3%
Q1 2015$3,789,000
+5.9%
92,026
+4.7%
0.01%0.0%
Q4 2014$3,579,000
+12.0%
87,856
+0.8%
0.01%
+20.0%
Q3 2014$3,195,000
-4.2%
87,157
+21.1%
0.01%
-16.7%
Q2 2014$3,335,000
+9.7%
71,991
-2.7%
0.01%
+20.0%
Q1 2014$3,040,000
+11.0%
73,972
+3.1%
0.01%0.0%
Q4 2013$2,739,00071,7820.01%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders